Assessing the Safety and Bioactivity of SG1002 in Heart Failure Patients
Clinical trial NCT02278276 · UNKNOWN
Trial details
- NCT number
- NCT02278276
- Sponsor
- Sulfagenix Australia Pty Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2018-04-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.